Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Fosun International Limited    0656   HK0656038673

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Fosun International : Voluntary Announcement – Preparation to Establish a Life Insurance Joint Venture Company

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2011 | 11:55am CET

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

VOLUNTARY ANNOUNCEMENT PREPARATION TO ESTABLISHA LIFE INSURANCE JOINT VENTURE COMPANY

The Board is pleased to announce that Fosun Industrial Technology, a wholly owned subsidiary of the Company and The Prudential Insurance Company of America, the United States insurance arm of Prudential Financial, Inc., have recently received a formal approval from the China Insurance Regulatory Commission on preparation to establish a life insurance joint venture company in China.

The board of directors (the “Board”) of Fosun International Limited (the “Company”) is pleased to announce that Shanghai Fosun Industrial Technology Development Company Limited (“Fosun Industrial Technology”), a wholly owned subsidiary of the Company and The Prudential Insurance Company of America, the United States insurance arm of Prudential Financial, Inc., an independent third party of the Company, have recently received a formal approval from the China Insurance Regulatory Commission on preparation to establish a life insurance joint venture company in China (the “Transaction”).

The life insurance joint venture company will start with a registered capital of RMB500 million with The Prudential Insurance Company of America and Fosun Industrial Technology each contributing 50 percent of it. The joint venture company is proposed to be headquartered in Shanghai.

The Board believes that China’s insurance business has great growth potential and the

Transaction fits into the long-term investment strategy of the Company.

The Transaction is conducted in the ordinary and usual course of business of the Company and does not constitute a notifiable transaction nor a connected transaction for the Company under Chapter 14 or Chapter 14A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

By Order of the Board Fosun International Limited Guo Guangchang

Chairman

Shanghai, the PRC, 15 September 2011

As at the date of this announcement, the executive directors of the Company are Mr. Guo Guangchang, Mr. Liang Xinjun, Mr. Wang Qunbin, Mr. Fan Wei, Mr. Ding Guoqi, Mr. Qin Xuetang and Mr. Wu Ping; the non- executive director is Mr. Liu Benren; and the independent non-executive directors are Dr. Chen Kaixian, Mr. Zhang Shengman and Mr. Andrew Y. Yan.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FOSUN INTERNATIONAL LIMITE
01/15 FOSUN INTERNATIONAL : Termination of discloseable transaction in relation to the..
01/15 FOSUN INTERNATIONAL : aims to become a world-class enterprise!
01/12 FOSUN INTERNATIONAL : Supplemental agreement for the discloseable transactions i..
2017 FOSUN INTERNATIONAL : biosimilar unit to raise $190M
2017 FOSUN INTERNATIONAL : Progress update on discloseable transactions in relation t..
2017 FOSUN INTERNATIONAL : beer deal
2017 FOSUN INTERNATIONAL : Nomura sees little synergy between Fosun & TB
2017 Jacobson Pharma (02633) to buy stake in Fosun Pharma's unit
2017 FOSUN INTERNATIONAL : Frenship 2.0 Fosun Happiness Paris – One Fosun&rsquo..
2017 FOSUN INTERNATIONAL : statement in relation to the recent updates on Yong’..
More news
News from SeekingAlpha
2017 WEEK IN REVIEW : Nearly $2 Billion Late-December Week For China Pharma Deals
2017 Disruptive beer deal in China
2017 WEEK IN REVIEW : Fosun May Pay $350 Million For Second India Pharma Acquisition
2017 Daily OTC Markets Round-Up - 9/18/2017
2017 Fosun International reports 1H results
Financials ( CNY)
Sales 2017 76 815 M
EBIT 2017 -
Net income 2017 12 248 M
Debt 2017 68 142 M
Yield 2017 1,44%
P/E ratio 2017 10,36
P/E ratio 2018 9,19
EV / Sales 2017 2,58x
EV / Sales 2018 2,33x
Capitalization 130 B
Chart FOSUN INTERNATIONAL LIMITE
Duration : Period :
Fosun International Limite Technical Analysis Chart | 0656 | HK0656038673 | 4-Traders
Technical analysis trends FOSUN INTERNATIONAL LIMITE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 20,0  CNY
Spread / Average Target 32%
EPS Revisions
Managers
NameTitle
Qun Bin Wang Chief Executive Officer & Director
Qi Yu Chen Co-President & Executive Director
Xiao Liang Xu Co-President & Executive Director
Guang Chang Guo Chairman
Can Wang Chief Financial Officer, Executive Director & SVP
Sector and Competitors
1st jan.Capitalization (M$)
FOSUN INTERNATIONAL LIMITED5.87%20 315
ARCELORMITTAL9.81%37 783
POSCO--.--%30 880
NIPPON STEEL & SUMITOMO METAL CORP-1.49%25 227
NUCOR8.45%21 920
THYSSENKRUPP3.37%19 063